Balaxi Pharmaceuticals Delivers Strong Growth in Q2 FY23
Hyderabad, Telangana, India
Revenue up 23%, Profit After Tax expands 29%
Pharma revenue up 50% with expanding contribution from Latin America
Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical company headquartered